Hidekazu Tanaka - Concepedia

Author

Hidekazu Tanaka

Also Known As

H T Tanaka, H TANAKA, H Tanaka, H. I. Tanaka, H. Tanaka, HIDEKAZU TANAKA, Hidekazu TANAKA, Hidekazu Tanaka, Mariko Okada, Mueller, Th A.

304

Publications

2.1K

Citations

H-Index

131

Concepts

All Affiliations

Gifu University Hospital Gifu University The University of Osaka Ijinkai Takeda General Hospital Yamaguchi University

About

Hidekazu Tanaka is an author at Gifu University Hospital specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	22	611
2	Health Sciences	10	10	208
3	Engineering	6	6	171
4	Arts	1	1	13
5	Language Studies	1	1	13

Hidekazu Tanaka

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Overview of KAGRA: Calibration, detector characterization, physical environmental monitors, and the geophysics interferometer T. Akutsu, Masaki Ando, K. Arai, Progress of Theoretical and Experimental Physics	2021	121
Use of 5-aminolevulinic acid in fluorescence-guided resection of meningioma with high risk of recurrence Yoshinaga Kajimoto, Toshihiko Kuroiwa, Shin‐Ichi Miyatake, Journal of neurosurgery	2007	103
Supernova Model Discrimination with Hyper-Kamiokande K. Abe, P. Adrich, H. Aihara, The Astrophysical Journal Neutrino PropertyHigh AccuracyNeutrino BurstExperimental Nuclear PhysicsEngineering	2021	79
Age-related variations in global spinal alignment and sagittal balance in asymptomatic Japanese adults Kunio Yokoyama, Masahiro Kawanishi, Makoto Yamada, Neurological Research	2017	70
Antitumor Efficacy of Hypothemycin, A New Ras‐signaling Inhibitor Hidekazu Tanaka, Kazuyo Nishida, Kenji Sugita, Japanese Journal of Cancer Research New DrugMedicineTumor GrowthPharmacologyImmunology	1999	62
Correlation of antiangiogenic and antitumor efficacy of N-biphenyl sulfonyl-phenylalanine hydroxiamic acid (BPHA), an orally-active, selective matrix metalloproteinase inhibitor. Ryuji Maekawa, Hideo Maki, Hitoshi Yoshida, PubMed Tumor BiologyAngiogenesisMatrix MetalloproteinaseMedicinePharmacology	1999	59
FLUORESCENCE OF NON-NEOPLASTIC, MAGNETIC RESONANCE IMAGING-ENHANCING TISSUE BY 5-AMINOLEVULINIC ACID Shin‐Ichi Miyatake, Toshihiko Kuroiwa, Yoshinaga Kajimoto, Neurosurgery	2007	56
Inhibition of gelatinolytic activity in tumor tissues by synthetic matrix metalloproteinase inhibitor: application of film in situ zymography. Masayuki Ikeda, Ryuji Maekawa, Hidekazu Tanaka, PubMed Chemoprevention StrategyGelatinolytic ActivityPathologyTumor TissuesTumor Biology	2000	52
Stereotactic body radiotherapy for very elderly patients (age, greater than or equal to 85 years) with stage I non-small cell lung cancer Shinya Hayashi, Hidekazu Tanaka, Y Kajiura, Radiation Oncology	2014	50
Modeling and cost-effectiveness analysis of etanercept in adults with rheumatoid arthritis in Japan: a preliminary analysis Makoto Tanno, Ichiro Nakamura, Katsumi Ito, Modern Rheumatology	2006	46

Page 1